WFDC2 and ovarian carcinoma: Risk of Ovarian Malignancy Algorithm (ROMA), which combines human epididymis protein 4 (HE4) and CA-125 levels with menopausal status to stratify the risk of ovarian cancer among patients with an ovarian mass, is practically used (30).